- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- News & PR
- News
- Market Currents
- Press Releases
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
KERX Market Currents
more »
KERX in Focus
more »
KERX Related Articles
more »
KERX News
more »
-
at MarketWatch.com (Apr 23, 2012)
-
at CNBC.com (Mar 6, 2012)
-
at CNBC.com (Nov 30, 2010)
-
at MarketWatch.com (Jul 14, 2010)
-
at MarketWatch.com (May 21, 2010)
KERX Press Releases and Filings
more »
-
PR Newswire (Mon, 8:30AM)
-
PR Newswire (May 10, 2012)
-
PR Newswire (May 9, 2012)
-
PR Newswire (May 8, 2012)
-
PR Newswire (May 7, 2012)
KERX Latest Transcript
more »
KERX Cramer
more »
-
Tue, May 11, 2010
KERX Instablog posts
more »
KERX vs. ETF Alternatives
Company Description
We are a biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including renal disease and cancer. We are developing Zerenex™ (ferric citrate), an oral,... More
